...
首页> 外文期刊>Supportive Care in Cancer >Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
【24h】

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

机译:对晚期或转移性乳腺癌患者每周紫杉醇化疗引起的周围神经病的前瞻性评估(CSP-HOR 02研究)

获取原文
获取原文并翻译 | 示例
           

摘要

Goals of work The aim of this study was to prospectively evaluate chemotherapy-induced peripheral neuropathy (CIPN) using a patient-based instrument, the Patient Neurotoxicity Questionnaire (PNQ) and a physician-based instrument, the National Cancer Institute-Common Toxicity Criteria (NCI-CTC) in patients with advanced or metastatic breast cancer who were treated with weekly paclitaxel.
机译:工作目标这项研究的目的是使用以患者为基础的仪器,患者神经毒性问卷(PNQ)和以医师为基础的仪器,国家癌症研究所通用毒性标准( NCI-CTC)每周接受紫杉醇治疗的晚期或转移性乳腺癌患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号